Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
1
RXST Quote, Financials, Valuation and Earnings
Last price:
$33.64
Seasonality move
:
22.68%
Day range:
$33.03 - $36.20
52-week range:
$33.03 - $66.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.91x
P/B ratio:
4.89x
Volume:
2.2M
Avg. volume:
836K
1-year change:
-11.74%
Market cap:
$1.4B
Revenue:
$89.1M
EPS (TTM):
-$0.82
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $14.7M | $22.6M | $49M | $89.1M | |
| Revenue Growth (YoY) | -- | 554.98% | 53.92% | 116.9% | 81.77% | |
| Cost of Revenues | $4.1M | $13M | $18.1M | $27.7M | $35.3M | |
| Gross Profit | -$1.8M | $1.7M | $4.5M | $21.3M | $53.8M | |
| Gross Profit Margin | -81.17% | 11.62% | 19.99% | 43.52% | 60.36% | |
| R&D Expenses | $29.6M | $21.9M | $24.5M | $26M | $29.1M | |
| Selling, General & Admin | $15.2M | $15.2M | $32.8M | $58.7M | $74.8M | |
| Other Inc / (Exp) | $170.6M | $63M | $7.7M | -- | -$1.8M | |
| Operating Expenses | $44.8M | $37.1M | $57.3M | $84.6M | $103.9M | |
| Operating Income | -$46.6M | -$35.4M | -$52.8M | -$63.3M | -$50.1M | |
| Net Interest Expenses | -- | -- | $3.6M | $3.4M | -- | |
| EBT. Incl. Unusual Items | $126.2M | $27.6M | -$48.7M | -$66.7M | -$48.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24K | $57K | $8K | $9K | $20K | |
| Net Income to Company | $126.2M | $27.6M | -$48.7M | -$66.8M | -$48.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $126.2M | $27.6M | -$48.7M | -$66.8M | -$48.6M | |
| Basic EPS (Cont. Ops) | $1.39 | $0.18 | -$3.57 | -$2.41 | -$1.41 | |
| Diluted EPS (Cont. Ops) | $1.39 | $0.18 | -$3.57 | -$2.41 | -$1.41 | |
| Weighted Average Basic Share | $18.8M | $19.1M | $13.6M | $27.7M | $34.5M | |
| Weighted Average Diluted Share | $18.8M | $19.1M | $13.6M | $27.7M | $34.5M | |
| EBITDA | $130.2M | $32.2M | -$41M | -$57.8M | -$41M | |
| EBIT | $126.3M | $28.1M | -$45M | -$61.8M | -$45.3M | |
| Revenue (Reported) | $2.2M | $14.7M | $22.6M | $49M | $89.1M | |
| Operating Income (Reported) | -$46.6M | -$35.4M | -$52.8M | -$63.3M | -$50.1M | |
| Operating Income (Adjusted) | $126.3M | $28.1M | -$45M | -$61.8M | -$45.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2M | $5.8M | $12.6M | $22.2M | $35.3M | |
| Revenue Growth (YoY) | -- | 38.75% | 118.03% | 75.97% | 59.08% | |
| Cost of Revenues | $3.5M | $4.4M | $7.3M | $8.5M | $10.1M | |
| Gross Profit | $720K | $1.3M | $5.4M | $13.7M | $25.2M | |
| Gross Profit Margin | 17.27% | 23.18% | 42.46% | 61.85% | 71.42% | |
| R&D Expenses | $5.8M | $5.4M | $6.4M | $7.1M | $8.8M | |
| Selling, General & Admin | $3.8M | $9.1M | $14.9M | $19.1M | $25.6M | |
| Other Inc / (Exp) | $39.5M | $1.5M | -- | -$1.4M | -- | |
| Operating Expenses | $9.6M | $14.5M | $21.3M | $26.2M | $34.4M | |
| Operating Income | -$8.9M | -$13.1M | -$16M | -$12.5M | -$9.2M | |
| Net Interest Expenses | -- | $1.1M | $860K | -- | -- | |
| EBT. Incl. Unusual Items | $30.7M | -$12.7M | -$16.8M | -$12.4M | -$6.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8K | -$4K | -- | $12K | $13K | |
| Net Income to Company | $30.7M | -$12.7M | -$16.8M | -$12.4M | -$6.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $30.7M | -$12.7M | -$16.8M | -$12.4M | -$6.3M | |
| Basic EPS (Cont. Ops) | $0.31 | -$0.68 | -$0.61 | -$0.35 | -$0.16 | |
| Diluted EPS (Cont. Ops) | $0.31 | -$0.68 | -$0.61 | -$0.35 | -$0.16 | |
| Weighted Average Basic Share | $19.1M | $18.7M | $27.7M | $35.7M | $39.8M | |
| Weighted Average Diluted Share | $19.1M | $18.7M | $27.7M | $35.7M | $39.8M | |
| EBITDA | $31.8M | -$10.6M | -$14.5M | -$11M | -$5.2M | |
| EBIT | $30.7M | -$11.6M | -$15.5M | -$12.2M | -$6.3M | |
| Revenue (Reported) | $4.2M | $5.8M | $12.6M | $22.2M | $35.3M | |
| Operating Income (Reported) | -$8.9M | -$13.1M | -$16M | -$12.5M | -$9.2M | |
| Operating Income (Adjusted) | $30.7M | -$11.6M | -$15.5M | -$12.2M | -$6.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $19.1M | $41.3M | $76.6M | $128.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $16.1M | $24.6M | $33.1M | $40.5M | |
| Gross Profit | -- | $3M | $16.8M | $43.5M | $87.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $23.9M | $25.2M | $28.4M | $32.5M | |
| Selling, General & Admin | -- | $25.6M | $54.6M | $69.4M | $94.4M | |
| Other Inc / (Exp) | $27.9M | $42.8M | -- | -$1.8M | -- | |
| Operating Expenses | -- | $49.4M | $79.8M | $97.8M | $126.9M | |
| Operating Income | -- | -$46.4M | -$63M | -$54.2M | -$39.1M | |
| Net Interest Expenses | -- | $3M | $3.9M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$6.7M | -$66.9M | -$55M | -$30.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $10K | $6K | $43K | $20K | |
| Net Income to Company | -- | -$6.7M | -$66.9M | -$55M | -$30.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$6.7M | -$66.9M | -$55M | -$30.7M | |
| Basic EPS (Cont. Ops) | -- | -$0.59 | -$2.44 | -$1.73 | -$0.82 | |
| Diluted EPS (Cont. Ops) | -- | -$0.59 | -$2.44 | -$1.73 | -$0.82 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | $415K | -$58.2M | -$46.1M | -$26.5M | |
| EBIT | -- | -$3.5M | -$62.3M | -$50.2M | -$30.7M | |
| Revenue (Reported) | -- | $19.1M | $41.3M | $76.6M | $128.3M | |
| Operating Income (Reported) | -- | -$46.4M | -$63M | -$54.2M | -$39.1M | |
| Operating Income (Adjusted) | -- | -$3.5M | -$62.3M | -$50.2M | -$30.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.8M | $14.2M | $32.9M | $60.5M | $99.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.4M | $12.5M | $19M | $24.4M | $29.6M | |
| Gross Profit | $324K | $1.6M | $13.9M | $36.1M | $70.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $16.7M | $18.6M | $19.3M | $21.7M | $25.2M | |
| Selling, General & Admin | $10.8M | $21.2M | $42.9M | $53.6M | $73.2M | |
| Other Inc / (Exp) | $27.9M | $7.7M | -- | -$1.8M | -- | |
| Operating Expenses | $27.4M | $39.8M | $62.2M | $75.3M | $98.4M | |
| Operating Income | -$27.1M | -$38.1M | -$48.3M | -$39.2M | -$28.2M | |
| Net Interest Expenses | -- | $2.6M | $2.8M | $115K | -- | |
| EBT. Incl. Unusual Items | $1.3M | -$32.9M | -$51.1M | -$39.4M | -$21.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $53K | $6K | $4K | $38K | $38K | |
| Net Income to Company | $1.3M | -$33M | -$51.1M | -$39.4M | -$21.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.3M | -$33M | -$51.1M | -$39.4M | -$21.5M | |
| Basic EPS (Cont. Ops) | -$1.67 | -$1.55 | -$1.86 | -$1.17 | -$0.57 | |
| Diluted EPS (Cont. Ops) | -$1.67 | -$1.55 | -$1.86 | -$1.17 | -$0.57 | |
| Weighted Average Basic Share | $57.2M | $64.1M | $82.7M | $101.8M | $115.1M | |
| Weighted Average Diluted Share | $57.2M | $64.1M | $82.7M | $101.8M | $115.1M | |
| EBITDA | $4.4M | -$27.4M | -$44.6M | -$32.9M | -$18.4M | |
| EBIT | $1.3M | -$30.3M | -$47.6M | -$36.1M | -$21.5M | |
| Revenue (Reported) | $9.8M | $14.2M | $32.9M | $60.5M | $99.7M | |
| Operating Income (Reported) | -$27.1M | -$38.1M | -$48.3M | -$39.2M | -$28.2M | |
| Operating Income (Adjusted) | $1.3M | -$30.3M | -$47.6M | -$36.1M | -$21.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8M | $14M | $24.4M | $11.8M | $9.7M | |
| Short Term Investments | $72.7M | $55M | $135M | $94M | $117.5M | |
| Accounts Receivable, Net | $789K | $2.9M | $4.9M | $11M | $20.3M | |
| Inventory | $7.2M | $8.3M | $8M | $14.8M | $17.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.5M | $1.4M | $4.1M | $3M | $3.5M | |
| Total Current Assets | $90.2M | $81.5M | $176.3M | $134.6M | $168.4M | |
| Property Plant And Equipment | $19.3M | $18.6M | $15.5M | $14.1M | $13.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $983K | $571K | $925K | $1.5M | $858K | |
| Total Assets | $110.4M | $100.7M | $192.7M | $150.2M | $182.6M | |
| Accounts Payable | $2.2M | $1.1M | $1.7M | $2.6M | $3.9M | |
| Accrued Expenses | -- | -- | $319K | $455K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $990K | $1.3M | $1.5M | $2M | $1.8M | |
| Other Current Liabilities | $463K | $5.8M | $1M | $2.3M | $2.6M | |
| Total Current Liabilities | $8.5M | $11.6M | $11.1M | $17.2M | $20.9M | |
| Long-Term Debt | -- | $24.4M | $39.8M | $40.2M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $415M | $398.2M | $54.5M | $60.3M | $22.2M | |
| Common Stock | $56.4M | $80.8M | $27K | $28K | $36K | |
| Other Common Equity Adj | $46K | -$3K | -$20K | -$95K | -$5K | |
| Common Equity | -$304.6M | -$297.5M | $138.2M | $89.9M | $160.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$304.6M | -$297.5M | $138.2M | $89.9M | $160.4M | |
| Total Liabilities and Equity | $110.4M | $100.7M | $192.7M | $150.2M | $182.6M | |
| Cash and Short Terms | $80.7M | $69M | $159.3M | $105.8M | $127.2M | |
| Total Debt | -- | $24.4M | $39.8M | $40.2M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $68.3M | $8.9M | $9.9M | $16.7M | |
| Short Term Investments | -- | $100M | $103.9M | $122M | $220.4M | |
| Accounts Receivable, Net | -- | $4.4M | $9M | $15.2M | $25.4M | |
| Inventory | -- | $9.4M | $15.3M | $18.9M | $21.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $4.3M | $2M | $1.9M | $2.6M | |
| Total Current Assets | -- | $186.3M | $139.2M | $167.9M | $286.8M | |
| Property Plant And Equipment | -- | $16.6M | $15M | $13.1M | $22.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $848K | $1.6M | $848K | $924K | |
| Total Assets | -- | $203.7M | $155.7M | $181.9M | $310.5M | |
| Accounts Payable | -- | $1.7M | $4.2M | $4.1M | $4.6M | |
| Accrued Expenses | -- | $6M | $10.2M | $12.9M | $17.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.5M | $1.9M | $2M | $734K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $9.2M | $16.4M | $18.9M | $22.6M | |
| Long-Term Debt | -- | $39.6M | $40M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $52.8M | $59.7M | $20.4M | $33.2M | |
| Common Stock | -- | $27K | $28K | $36K | $40K | |
| Other Common Equity Adj | -- | -$11K | -$138K | -$60K | $521K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $150.9M | $96M | $161.5M | $277.3M | |
| Total Liabilities and Equity | -- | $203.7M | $155.7M | $181.9M | $310.5M | |
| Cash and Short Terms | -- | $168.3M | $112.8M | $131.9M | $237.1M | |
| Total Debt | -- | $39.6M | $40M | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $126.2M | $27.6M | -$48.7M | -$66.8M | -$48.6M | |
| Depreciation & Amoritzation | $3.9M | $4M | $4M | $4M | $4.2M | |
| Stock-Based Compensation | $4.6M | $4.2M | $7.6M | $11.4M | $15.7M | |
| Change in Accounts Receivable | -$789K | -$2.1M | -$2M | -$6.1M | -$9.3M | |
| Change in Inventories | -$5.5M | -$1.3M | -$2.1M | -$7.6M | -$2.7M | |
| Cash From Operations | -$40.6M | -$35.2M | -$44.7M | -$58.9M | -$41.6M | |
| Capital Expenditures | $4.1M | $2.5M | $1.9M | $2.4M | $4.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5.9M | $15.6M | -$81.9M | $40M | -$22.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $25M | $15M | -- | $20M | |
| Long-Term Debt Repaid | -$185K | -$142K | -$27K | -$121K | -$60.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$76K | -$636K | $443K | -$1.4M | -$4.3M | |
| Cash From Financing | $1.3M | $25.2M | $137.3M | $6.3M | $61.5M | |
| Beginning Cash (CF) | $54M | $8.8M | $14.5M | $25.2M | $12.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$45.2M | $5.6M | $10.7M | -$12.6M | -$2.2M | |
| Ending Cash (CF) | $8.8M | $14.5M | $25.2M | $12.6M | $10.4M | |
| Levered Free Cash Flow | -$44.7M | -$37.7M | -$46.6M | -$61.2M | -$46.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $30.7M | -$12.7M | -$16.8M | -$12.4M | -$6.3M | |
| Depreciation & Amoritzation | $1.1M | $1M | $980K | $1.1M | $1.1M | |
| Stock-Based Compensation | $1.2M | $2M | $2.9M | $4.1M | $6.6M | |
| Change in Accounts Receivable | -$475K | -$421K | -$2.1M | -$2M | $320K | |
| Change in Inventories | -$28K | -$1.5M | -$4M | -$977K | -$2.4M | |
| Cash From Operations | -$6.9M | -$13.8M | -$15.2M | -$8M | $650K | |
| Capital Expenditures | $603K | $254K | $580K | $653K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $6.4M | -$80.2M | $560K | $17.3M | -$9.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$28K | -$5K | -$22K | -$20M | -$11K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$13K | $134K | -$578K | -$2.1M | -$2.9M | |
| Cash From Financing | $52K | $120.5M | -$455K | -$8.2M | $878K | |
| Beginning Cash (CF) | $13.4M | $42.3M | $24.8M | $9.5M | $25.2M | |
| Foreign Exchange Rate Adjustment | -$9K | -$4K | -$9K | -$5K | $7K | |
| Additions / Reductions | -$491K | $26.6M | -$15.1M | $1.1M | -$7.7M | |
| Ending Cash (CF) | $12.9M | $68.8M | $9.7M | $10.6M | $17.4M | |
| Levered Free Cash Flow | -$7.6M | -$14M | -$15.8M | -$8.6M | -$453K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$6.7M | -$66.9M | -$55M | -$30.7M | |
| Depreciation & Amoritzation | -- | $4M | $4.1M | $4.1M | $4.2M | |
| Stock-Based Compensation | $2.9M | $5.9M | $11.4M | $14.3M | $21.8M | |
| Change in Accounts Receivable | -- | -$2.9M | -$4.7M | -$6.2M | -$10.2M | |
| Change in Inventories | -- | -$2.9M | -$6.4M | -$3.9M | -$3.2M | |
| Cash From Operations | -- | -$44.2M | -$53.7M | -$47.1M | -$21M | |
| Capital Expenditures | $2M | $2.1M | $2.4M | $3.6M | $6.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$61.1M | -$5.8M | -$16.3M | -$96.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $40M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$32K | -$88K | -$60.2M | -$83K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$492K | -$848K | -$4.6M | -$5.5M | |
| Cash From Financing | -- | $161.3M | $429K | $64.3M | $123.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $56M | -$59.1M | $834K | $6.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$46.3M | -$56.1M | -$50.7M | -$27.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3M | -$33M | -$51.1M | -$39.4M | -$21.5M | |
| Depreciation & Amoritzation | $3M | $3M | $3.1M | $3.2M | $3.1M | |
| Stock-Based Compensation | $2.9M | $4.7M | $8.4M | $11.3M | $17.4M | |
| Change in Accounts Receivable | -$650K | -$1.5M | -$4.2M | -$4.3M | -$5.1M | |
| Change in Inventories | -$1.9M | -$3.5M | -$7.8M | -$4.1M | -$4.6M | |
| Cash From Operations | -$27M | -$36M | -$45M | -$33.3M | -$12.7M | |
| Capital Expenditures | $2M | $1.6M | $2M | $3.2M | $4.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $30.1M | -$46.6M | $29.5M | -$26.7M | -$100.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $15M | -- | $20M | -- | |
| Long-Term Debt Repaid | -$131K | -$21K | -$82K | -$60.1M | -$49K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $65K | $209K | -$1.1M | -$4.3M | -$5.5M | |
| Cash From Financing | $909K | $136.9M | $25K | $58M | $120.3M | |
| Beginning Cash (CF) | $43.1M | $81.6M | $74.9M | $33.9M | $68.9M | |
| Foreign Exchange Rate Adjustment | -$7K | -$7K | -$23K | -$2K | $3K | |
| Additions / Reductions | $4M | $54.4M | -$15.4M | -$2M | $7M | |
| Ending Cash (CF) | $47.1M | $136M | $59.5M | $31.9M | $75.9M | |
| Levered Free Cash Flow | -$29M | -$37.6M | -$47M | -$36.5M | -$17.3M | |
Get RXST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RXST
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
4.89x
1.85x
Price / LTM sales
9.91x
1.86x
Growth Metrics
RXST
Sector
Revenue growth
59.08%
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.07
-$0.20
Profitability
RXST
Sector
Profitability FY 2023
$53.8M
$57.1M
Return on invested capital
-14.78%
-14.06%
Return on assets
-13.19%
-11.77%
Return on equity
-14.78%
-14.78%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Feb
6
Balance Sheet
RXST
Sector
Total cash
$237.1M
$47M
Short term investments
$117.5M
$45.2M
Total assets
$182.6M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
